Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Leigh disease - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Leigh disease - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...

May 2021 60 pages

Major Depressive Disorder - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Major Depressive Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ p...

May 2021 120 pages

Methicillin-Resistant Staphylococcus Aureus Infections - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Methicillin-Resistant Staphylococcus Aureus Infections - Pipeline Insight, 2021,” report provides comprehensive insights...

May 2021 60 pages

Pneumococcal infections - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Pneumococcal infections – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pip...

May 2021 60 pages

Polycystic ovary syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Polycystic ovary syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pip...

May 2021 60 pages

Pyoderma gangrenosum - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Pyoderma gangrenosum - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...

May 2021 60 pages

Sepsis - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sepsis - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Se...

May 2021 80 pages

Ulcerative Colitis - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Ulcerative Colitis - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 110+ pipeli...

May 2021 200 pages

Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Wet Age-Related Macular Degeneration (Wet-AMD) - Pipeline Insight, 2021,” report provides comprehensive insights about 70...

May 2021 190 pages

Vasomotor Symptoms - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Vasomotor Symptoms - Pipeline Insight, 2021,” report provides comprehensive insights about 9+ companies and 9+ pipeline d...

May 2021 60 pages

Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 24 Hours DelveInsight’s, “Alpha-1 Antitrypsin Deficiency (A1ATD) Liver Disease - Pipeline Insight, 2021,” report provides comprehensive insights ab...

May 2021 60 pages

Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Atypical Teratoid Rhabdoid Tumors (ATRT) - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ comp...

May 2021 60 pages

Scleroderma - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Scleroderma - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs...

May 2021 100 pages

Acute Ischemic Stroke - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Acute Ischemic Stroke – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipel...

May 2021 60 pages

Adenovirus infections - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Adenovirus infections – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipelin...

May 2021 60 pages

Anti-CD20 antibody - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Anti-CD20 antibody – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline...

May 2021 60 pages

Atherosclerosis - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Atherosclerosis – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline dr...

May 2021 60 pages

BK Virus infections - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “BK Virus infections – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...

May 2021 60 pages

Chronic hand eczema - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic hand eczema - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...

May 2021 60 pages

Gilles de la Tourette’s syndrome

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Gilles de la Tourette’s syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and...

May 2021 60 pages

Lipodystrophy - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Lipodystrophy – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drug...

May 2021 60 pages

Methylmalonic academia - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Methylmalonic academia - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...

May 2021 60 pages

Middle East respiratory syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Middle East respiratory syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...

May 2021 60 pages

Neutropenia - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Neutropenia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 30+ pipeline drugs...

May 2021 60 pages

Sialorrhoea - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sialorrhoea – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in...

May 2021 60 pages

Sleep apnoea syndrome - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sleep apnoea syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipel...

May 2021 60 pages

Tendinitis - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Tendinitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in...

May 2021 60 pages

Vertigo - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Vertigo - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Ver...

May 2021 60 pages

Global Pharmaceutical Logistics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)

US$ 900.00

of the Report The report titled “Global Pharmaceutical Logistics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global pharmaceutical logi...

May 2021 87 pages

COVID-19 - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “COVID-19 - Pipeline Insight, 2021,” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs i...

May 2021 300 pages

Psoriasis - Pipeline Insight, 2021

US$ 3,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Psoriasis - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs...

May 2021 200 pages

T cell lymphoma - Pipeline Insight, 2021

US$ 2,500.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “T cell lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 120+ pipeline...

May 2021 200 pages

Brain Metastases - Pipeline Insight, 2021

US$ 2,000.00

This report can be delivered to the clients within 72 Hours DelveInsight’s, “Brain Metastases – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline d...

May 2021 60 pages

Thymoma - Pipeline Insight, 2021

US$ 1,500.00

This report can be delivered to the clients within 48 Hours DelveInsight’s, “Thymoma – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Thy...

May 2021 60 pages

1,3 Beta Glucan Synthase (EC 2.4.1.34) - Drugs in Development, 2021

US$ 3,000.00

1,3 Beta Glucan Synthase (EC 2.4.1.34) - Drugs in Development, 2021 SUMMARY 1,3 Beta Glucan Synthase (EC 2.4.1.34) - Drugs in Development, 2021 provides in depth analysis on 1,3 Beta Glucan Synthase (...

April 2021 30 pages

16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021

US$ 3,000.00

16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 SUMMARY 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 provides in depth analysis on 16S Ribosomal RNA (16S rRNA) targeted pipeline...

April 2021 85 pages

23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021

US$ 3,000.00

23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 SUMMARY 23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 provides in depth analysis on 23S Ribosomal RNA (23S rRNA) targeted pipeline...

April 2021 70 pages

30S Ribosomal Subunit (30S RNA) - Drugs in Development, 2021

US$ 3,000.00

30S Ribosomal Subunit (30S RNA) - Drugs in Development, 2021 SUMMARY 30S Ribosomal Subunit (30S RNA) - Drugs in Development, 2021 provides in depth analysis on 30S Ribosomal Subunit (30S RNA) targeted...

April 2021 40 pages

3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) - Drugs in Development, 2021

US$ 3,000.00

3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) - Drugs in Development, 2021 SUMMARY 3C Like Proteinase (3CL-PRO or 3CLp or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analysis on 3C...

April 2021 60 pages

5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1...

April 2021 115 pages

5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or S...

April 2021 55 pages

5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D Alpha Receptor or Serotonin Receptor 1D or HTR1D) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 1D (5 HT1D or Serotonin 1D A...

April 2021 60 pages

5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 2 (5 HT2 Receptor or HTR2) - Drugs in Development, 2021 provides in depth anal...

April 2021 45 pages

5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 2A (5 HT2A or Serotonin Receptor 2A or HTR2A) - Drugs in De...

April 2021 170 pages

5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxytryptamine Receptor 1C or Serotonin Receptor 2C or HTR2C) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 2C (5 HT2C or 5 Hydroxyt...

April 2021 50 pages

5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 3 (5HT3 or 5 HT3 Receptor or HTR3) - Drugs in Development, 2021 provid...

April 2021 60 pages

5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 4 (5 HT4 or Serotonin Receptor 4 or HTR4) - Drugs in Developmen...

April 2021 40 pages

5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) - Drugs in Development, 2021

US$ 3,000.00

5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) - Drugs in Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor (Serotonin Receptor or 5 HT Receptor or HTR) - Drugs in Deve...

April 2021 40 pages

50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021

US$ 3,000.00

50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021 SUMMARY 50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021 provides in depth analysis on 50S Ribosomal Subunit (50S RNA) targeted...

April 2021 30 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1